Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Iris Yeong-Fung Sheng, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Sheng IY, Barata P, Alameddine R, Garcia JA. Volume matters and intensification is needed: emerging trends in the management of advanced prostate cancer. Drugs Context. 2021; 10. PMID: 33796138.
    Citations:    
  2. Sheng IY, Fallah J, Gupta R, Li H, Allman K, Martin A, Barata P, Ornstein MC, Gilligan TD, Rini BI, Garcia JA. Identifying Prostate Surface Antigen Patterns of Change in Patients with Metastatic Hormone Sensitive Prostate Cancer Treated with Abiraterone and Prednisone. Target Oncol. 2020 08; 15(4):477-483. PMID: 32661959.
    Citations:    Fields:    
  3. Sheng IY, Wei W, Chen YW, Gilligan TD, Barata PC, Ornstein MC, Rini BI, Garcia JA. Implications of the United States Preventive Services Task Force Recommendations on Prostate Cancer Stage Migration. Clin Genitourin Cancer. 2021 02; 19(1):e12-e16. PMID: 32800474.
    Citations:    Fields:    Translation:HumansPHPublic Health
  4. Sheng IY, Ornstein MC. Ipilimumab and Nivolumab as First-Line Treatment of Patients with Renal Cell Carcinoma: The Evidence to Date. Cancer Manag Res. 2020; 12:4871-4881. PMID: 32606975.
    Citations: 4     
  5. Gupta R, Sheng IY, Barata PC, Garcia JA. Non-metastatic castration-resistant prostate cancer: current status and future directions. Expert Rev Anticancer Ther. 2020 06; 20(6):513-522. PMID: 32508166.
    Citations:    Fields:    Translation:Humans
  6. Sheng IY, Diaz-Montero CM, Rayman P, Wei W, Finke JH, Kim JS, Pavicic PG, Lamenza M, Company D, Stephenson A, Campbell S, Haber G, Lee B, Mian O, Gilligan TD, Rini BI, Garcia JA, Grivas P, Ornstein MC. Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial Carcinoma. Target Oncol. 2020 04; 15(2):211-220. PMID: 32207064.
    Citations: 7     Fields:    Translation:HumansCells
  7. Sheng IY, Rini BI. Immunotherapy for renal cell carcinoma. Expert Opin Biol Ther. 2019 09; 19(9):897-905. PMID: 31173514.
    Citations: 2     Fields:    Translation:Humans
  8. Sheng IY, Kruse M, Leininger KM, Ornstein MC. Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC). Case Rep Oncol Med. 2019; 2019:6246209. PMID: 31281697.
    Citations:    
  9. Safran H, Leonard KL, Perez K, Vrees M, Klipfel A, Schechter S, Oldenburg N, Roth L, Shah N, Rosati K, Rajdev L, Mantripragada K, Sheng IY, Barth P, DiPetrillo TA. Tolerability of ADXS11-001 Lm-LLO Listeria-Based Immunotherapy With Mitomycin, Fluorouracil, and Radiation for Anal Cancer. Int J Radiat Oncol Biol Phys. 2018 04 01; 100(5):1175-1178. PMID: 29722659.
    Citations: 13     Fields:    Translation:HumansCells
  10. Sheng IY, Treaba DO, Bishop KD. Infiltrative Rash Secondary to Leukemic-Phase Diffuse Large B-Cell Lymphoma With t(14;18), CDKN2A and MLL Deletion. J Hematol. 2017 Oct; 6(4):90-95. PMID: 32300400.
    Citations:    
  11. Raghunathan VM, Sheng I, Lim SH. Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation. J Transl Med. 2016 12 03; 14(1):335. PMID: 27912759.
    Citations: 2     Fields:    Translation:Humans
  12. Sheng I, Bauza A, Langer P, Zarbin M, Bhagat N. A 10-year review of open-globe trauma in elderly patients at an urban hospital. Retina. 2015 Jan; 35(1):105-10. PMID: 25127048.
    Citations: 7     Fields:    Translation:Humans
  13. Kolomeyer AM, Nayak NV, Simon MA, Szirth BC, Shahid K, Sheng IY, Xia T, Khouri AS. Feasibility of retinal screening in a pediatric population with type 1 diabetes mellitus. J Pediatr Ophthalmol Strabismus. 2014 Sep-Oct; 51(5):299-306. PMID: 25020279.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  14. Shah A, Szirth B, Sheng I, Xia T, Khouri AS. Optic disc drusen in a child: diagnosis using noninvasive imaging tools. Optom Vis Sci. 2013 Oct; 90(10):e269-73. PMID: 24064526.
    Citations: 1     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Sheng's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (68)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.